DORATHY OFFIAH: Open Payments
NPI 1861032740 · LINDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 37 payments from 13 companies in 2025. Trend: 2023 $156 · 2024 $182 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $270 |
| Novo Nordisk Inc | 5 | $101 |
| Dexcom, Inc. | 5 | $89 |
| Kowa Pharmaceuticals America, Inc. | 4 | $59 |
| Lilly USA, LLC | 3 | $56 |
| Amgen Inc. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| Ardelyx, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $19 |
Products named: AIRSUPRA, BREZTRI, Dexcom G6 Transmitter, JARDIANCE, Ozempic, ZORYVE, FARXIGA, EVENITY.
Industry payments across NJ — which companies pay providers there.
